Panacea Biotec's lenders approve one-time settlement of outstanding dues

10 Apr 2019 Evaluate

Panacea Biotec’s  lenders has approved a one-time settlement plan to clear outstanding dues. All consortium lenders have approved the bilateral one-time settlement (OTS) at 65% of their outstanding debts.

The settlement has been done to resolve the current debt position of the company.

Panacea Biotec is a leading research based Biotechnology Company with established research, manufacturing and marketing capabilities. It is one of the largest vaccine producers and biotechnology companies in India.

Panacea Biotec Share Price

133.00 -0.75 (-0.56%)
13-Jun-2024 13:41 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1505.75
Dr. Reddys Lab 6072.50
Cipla 1539.25
Zydus Lifesciences 1090.00
Lupin 1607.95
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.